Industry Sessions

Industry sessions will be held over lunch on Thursday and Friday at the ICC Sydney. Attendees are invited to consume their lunch in the Exhibition before making their way back to the Pyrmont Theatre for the session. 

Pre-registration is required to attend these sessions; this can be completed through the online registration form. Places are strictly limited and are offered on a first come, first served basis. We recommend booking early to ensure you don’t miss out.

Delving Into Endometriosis Pain Management: From Adolescence to Family Planning
Date: Thursday 22 May 2025
Time: 1320-1420hrs
Location: Pyrmont Theatre, Level 2, International Convention Centre Sydney
Cost: Included for all full registrations. Additional tickets cannot be purchased for this session
Chair: , Fertility Plus, New Zealand
Presenters

  • , The University of New South Wales, Australia
  • , The University of New South Wales, Australia
  • Professor Juan Garcia Velasco, IVI Madrid, Spain

This symposium brings together leading experts to explore early detection, pain management, and fertility challenges related to endometriosis. Open to all Congress attendees, this symposium, chaired by Professor Neil Johnson, will cover key strategies to improve outcomes for women at every stage of their journey.

Sponsored by 


The Salivary miRNA Signature: Unlocking the Early Diagnosis of Endometriosis
Date: Friday 23 May 2025
Time: 1320-1420hrs
Location: Pyrmont Theatre, Level 2, International Convention Centre Sydney
Cost: Included for all full registrations. Additional tickets cannot be purchased for this session. 
Chair: TBC
Presenters:
  • Professor Jason Abbott, The University of New South Wales, Australia
  • Dr Mauricio Abrao, Sao Paulo University and Hospital BP - A Beneficencia Portuguesa de São Paulo, Brazil
  • Professor Sun-Wei Guo, Shanghai Obstetrics and Gynecology Hospital, Fudan University, China
  • Dr Yuval Kaufman, Carmel Medical Center, Affiliated fo the Technion Institute of Technology, Israel

Ziwig® Endotest Saliva Based Test for Diagnosis of Endometriosis“The Salivary miRNA Signature: Unlocking the Early Diagnosis of Endometriosis.”

Ziwig Endotest® is a cutting-edge, non-invasive diagnostic tool designed to detect endometriosis using a simple saliva sample. Targeted at women aged 18-43 with symptoms suggestive ofendometriosis, this in vitro test integrates advanced micro-RNA sequencing with artificial intelligence to deliver highly accurate results (over 95% diagnostic accuracy) for all phenotypes ofthe disease.

Validated by the largest clinical study in the field, involving 1,000 patients, Ziwig Endotest® significantly shortens diagnostic delays—currently averaging 7-10 years—and reduces the need forinvasive procedures like laparoscopy. This innovation not only enhances diagnostic precision but also improves patient outcomes by facilitating earlier intervention and personalized care.

Join us to explore how Ziwig Endotest® is revolutionizing endometriosis diagnosis and advancing Women’s health globally. Target audience includes clinicians and other health professionals,researchers, laboratory-based scientists, patient advocates, industry delegates and policy makers.

Sponsored by



The 16th World Congress on Endometriosis is proudly hosted by

and supported by

Acknowledgement of Country
The 16th Congress on Endometriosis acknowledges the Traditional Owners of the lands on which we will meet, the Gadigal people of the Eora Nation. We pay our respects to their Elders past, present and emerging.

WaldronSmith Logo
WALDRONSMITH Management
119 Buckhurst Street
South Melbourne VIC 3205 Australia
T +61 3 9645 6311
E wce2025@wsm.com.au